Centaur Labs recognized in 2021 CB Insights Digital Health 150

Erik Duhaime, Co-founder and CEO
January 18, 2022

We’re humbled and honored to be recognized by CB Insights as one of the top 150 digital health startups in the world!

CB Insights selected startups for its Digital Health 150 list based on business models, momentum in the market, Mosaic scores, overall health and growth potential measured by CB Insights’ proprietary algorithm, and other data submitted by companies.

CB Insights’ 2021 Digital Health 150 cohort raised ~$14.9B in aggregate funding across 522 deals since 2016. The cohort includes startups at various stages of development, from early-stage companies all the way to unicorns. (Read the full CB Insights article here)

We’re so proud of our team’s hard work and dedication. Come join us in advancing the medical AI revolution!

Related posts

February 2, 2022

Just published: effects of disease prevalence and feedback on dermatological decision making

Our research collaboration with Dr. Jeremy M Wolfe just published in Cognitive Research: Principles and Implications.

Continue reading →
January 10, 2021

From MVP to scaleup: how to 10X your medical data labeling pipeline

Understand why traditional labeling pipelines are so hard to scale and learn how our solution can 10X your labeling pipeline in a shorter time frame and with higher accuracy

Continue reading →
October 20, 2020

The power of metadata

Understand how Centaur Labs' data annotation platform offers richer results than traditional data labeling vendors

Continue reading →